Longevity drug developer Loyal and pain therapy manufacturer Elanco Animal Health are working with the organization to ...

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide. It offers pet health products, such as ...

Elanco Animal Health (NYSE:ELAN) traded lower in the premarket on Tuesday after the veterinary product maker, with its Q4 2024 results, set its full-year outlook below consensus, citing an ...

Note that this product is not used in organically certified dairy products. -- Elanco has posted an advisory for its widely used immunosuppressant drug, Apoquel, for dogs with skin problems.

Elanco missed analysts’ revenue expectations by 0.6% last quarter, reporting revenues of $1.03 billion, down 3.6% year on year. It was a mixed quarter for the company, with a solid beat of ...

As of December 31, 2024, Elanco's net leverage ratio was 4.3x adjusted EBITDA, flat to September 30, 2024. The company anticipates a headwind to revenue of approximately $110 million from the ...

In its fourth quarter 2024 investor letter, Hardman Johnston Global Equity Strategy emphasized stocks such as Elanco Animal Health Incorporated (NYSE:ELAN). Elanco Animal Health Incorporated (NYSE ...

Elanco Animal's Outlook Lags Street Expectations But Analyst Sees Time For Elanco's Commercial Investment To Payoff Elanco's Q4 revenue reached $1.02 billion, topping estimates, but EPS missed ...

In this article, we are going to take a look at where Elanco Animal Health Incorporated (NYSE:ELAN) stands against the other most undervalued biotech stocks to invest in. Trump’s Tariffs and the ...